When you visit Doe Deere’s Instagram page, you will be welcomed by numerous pictures of Deere wearing bright makeups and face paints, which define her innovative brand, Lime Crime. However, there is more to Deere than just a cute face with colorful makeup. She is a talented businessperson and a fashion designer. She featured on Self-Made Magazine as one of the Leading Inspiring Female Entrepreneurs after creating her fastest growing brand.
Doe Deere was artistic and imaginative even when she was a child. On her hands, she never lacked paints and pencils. She had easy access to her mom’s makeup and always applied as much color as possible on herself.
Origin of the name “Lime Crime”
She decided to go by the name Lime Crime since at the time; silly handles were trending on the Internet. Additionally, the name not only rhymed but also invoked bright green, which was her favorite color. Today, Lime Crimes stands for a revolution of colors, breaking the fashion rules, and being innovative with colors. Rather than conforming to fashion rules, Lime Crimes encourages fashion enthusiast to enjoy and have fun while using colors.
Deere gets an immediate feedback from her clients and followers when she launches new products. She takes negative criticisms positively and uses them to improve the quality of her products. She responds to queries and complaints from customers in a prompt and professional manner. Deere calls her fans Unicorns since she believes they were born unique and are proud of it.
Doe Deere is a Russian-born fashion guru, who founded Lime Crime in 2008 and currently serves as its CEO. Her desire to come up with makeup that complimented her clothes that sold on eBay compelled Deere to launch Lime Crime Makeup. In 2009, Lime Crime became the first firm to deploy to the market distinct and unique lip colors. In 2012, the company introduced its first velvetines and became a market leader in the highly famous trend of liquid to matte lipstick.
Since she started out humbly and rose to greatness, Deere supports other businesses and startups owned by women. She graces public events like Vegas Nay’s Stardust Tour and PHAMExpo and speaks on the topic of following your passion and finding your voice. She likes encouraging other ambitious female entrepreneurs and interacts with them through a Facebook account and Instagram.
Learn more: http://guestofaguest.com/los-angeles/interview/interview-lime-crimes-doe-deere-on-how-to-make-your-dreams-come-true
Lovaganza has finally announced the dates for its much anticipated “Global Celebration.” The celebration of people and cultures from around the world will take place in May through September 2020 in eight locations throughout the world. The Lovaganza celebration will allow people to participate in this “bohemian adventure” by way of a virtual experience in order to bring a mutual respect and understanding of all people and their cultures to create a harmony among mankind. At each of these locations, people of all walks of life will be encouraged to participate in being immersed in different cultures from America through Asia.
People who attend the celebrations will be able to be exposed to the variety of cultures through several activities which include three major films that will be presented on innovative Immerscope screens. These new, advanced screens are to be similar to the ones once used in Cinerama which captivated audiences in the 1950s.
Prior to the celebration in 2020, a Traveling Show will be launched in 2017. This traveling show will introduce the concepts of the 2020 celebration by presenting Lovaganza’s mission of love and embracing those of other cultures. It will also provide a demonstration of the Immerscope movies.
The celebration was originally scheduled to take place in 2015, but due to the new technologies of the Immerscope screens and other advances that would heighten the experience, Lovaganza chose to postpone the celebration until 2020. This will allow the people who visit the celebrations to be more thoroughly immersed in the cultures of others and will further promote the Lovaganza mission to “to inspire Humanity to create a New World of Unity, Peace and Abundance for All.”
The Lovaganza Entertainment Franchise is the for-profit venture that involves the various entertainment aspects of the celebration in order to introduce and immerse individuals using top of the line technology on Facebook. It makes it possible to present these cultures to people who otherwise may never experience them in any other way. The Lovaganza Foundation is the non-profit part that takes the participant from immersion of other cultures to an understanding and respect for all mankind. Together the two parts allow Lovaganza to present a greater message of love and respect for all mankind.
Learn more about Lovaganza: https://twitter.com/Lovaganza_
Lovaganza from J-Scott on Vimeo.
Seattle Genetics recently had a earnings release conference call, summing up major milestones hit and what the company can expect in the future. Their major, FDA-approved drug, ADCETRIS, the company reported record net sales in the second quarter of 2016 and are approaching Phase 3 trial top-line data that should support a future label expansion for CD30-expressing lymphomas. Their second most promising drug, SGN-CD33A has five ongoing clinical trials which include a pivotal Phase 3 trial targeted for AML patients. This Phase 3 trial, termed CASCADE is for older patients with AML that express CD33A protein, and the results are eagerly awaited by investors. Additionally, the academic journal Blood published a 5-year followup study of the company’s ADCETRIS trial with data indicating all of the 102 enrolled patients had a five-year overall survival rate of 41%. Of note, patients who achieved a complete remission had five-year overall survival of 64%.
Seattle Genetics (SGEN) Clay B. Siegall on Q2 2016 Results – Earnings Call Transcript
The company, with record sales of ADCETRIS, had total revenues of $95.4 million – up 24% from last quarter. This is in line with what the company previously forecasted for U.S. and canada of $255-275 million for the fiscal year.
Clay Siegall is the President and CEO of Seattle Genetics since 1998. He also has executive and important positions in Alder Biopharmaceuticals, which deals with migraines and Cushings disease, Mirna Therapeutics, which deals with miRNA -based therapies, and Ultragenyx Pharmaceutical which deals with rare and ultra-rare genetic diseases.
Synergistically, Clay’s ability to provide leadership roles and guidance in these companies and move them forward in the biotechnology field, which has been volatile and chaotic most recently, indicates a strong understanding of how to bring value to these companies and investors. With Seattle Genetics approaching 1-year highs in stock price, we can likely expect strong data, leadership, and progress moving forward, with Mr. Siegall at the steering wheel.